Oral etoposide for kaposi’s mediterranean sarcoma

Dermatology

Volumn 177, Issue 6, 1988, Pages 365-369

  Brambilla, Lucia ^a   Boneschia, V ^a   Fossati, S ^a   Melotti, E ^a   Clericib, M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UO of Pediatric and Neonatal Pathology   (Italy)

Author keywords

Etoposide; Kaposi s Mediterranean sarcoma; Systemic oral chemotherapy

Indexed keywords

ETOPOSIDE; VINBLASTINE;

ADULT; AGED; BLOOD TOXICITY; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KAPOSI SARCOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN CANCER;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMPARATIVE STUDY; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FEMALE; HUMAN; MALE; MIDDLE AGE; SARCOMA, KAPOSI; VINBLASTINE;

EID: 0024214675     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000248608     Document Type: Article

References (16)

1. Modlin RL, Crissey, JT, Rea, TH: Kaposi’s sarcoma. Int J Dermatol 1983;443-447.
2. Bauduceau BB, Moretti G: Maladie de Kaposi et lymphome malin: Discussion de cette association. Ann Dermatol Venereol 1977;104:817-823.
3. Beurey J, Weber M, Mazet J, et al: Association;maladie de Kaposi-maladie de Hodgkin. Ann Dermatol Syph 1976;103/2:151-159.
4. Raika G: Kaposi’s sarcoma associated with Hodgkin disease. Acta Dermatol Venereol 1965;45: 40-43.
5. Safai B, Mike V, Giraldo G, et al: Association of Kaposi’s sarcoma with second primary malignancies. Cancer 1980;45:1472-1479.
6. Ulbright TM, Santa Cruz DJ: Kaposi’s sarcoma:;Relationship with haematologic, lymphoid and;thymic neoplasia. Cancer 1981;47:963-973.
7. Brambilla L, Boneschi V, Beretta G, et al: Intra-lesional chemotherapy for Kaposi’s sarcoma. Dermatologica 1984;169:150-155.
8. Odon RB, Detlet LT, Goette K: Treatment of cutaneous Kaposi’s sarcoma intralesional vincristine. Arch Dermatol 1978;114:1963-1964.
9. Brambilla L, Clerici M: Treatment of Kaposi’s sarcoma with Vinca alkaloids. Ital Gen Rew Dermatol 1980;17:89-96.
10. Brambilla L, Boneschi V, Beretta G, et al: Chemotherapeutic approach to Kaposi’s sarcoma; in Cerimele D (ed): Kaposi’s Sarcoma, New York, Spectrum, 1985, pp 137-148.
11. Goldman J, Greenwald ES, Schulman PI: Vinblastine therapy of Kaposi’s sarcoma. NY State J;Med 1974;74:1828-1831.
12. Solon AJ, Greenwald ES, Silvay O: Long-term complete remission of Kaposi’s sarcoma with vinblastine therapy. Cancer 1981;47:637-639.
13. Laubenstein LJ, Krigel RL, Hymes KB, et al: Treatment of epidemic Kaposi’s sarcoma with VP16-213 (etoposide) and a combination of doxorubicin,;bleomycin and vinblastine (ABV) (abstract;C-892). Proc ASCO 1983, p 228.
14. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 1981;47:207-214.
15. Ruszczak Z, Mayer-Da Silva A, Orfanos CE: Kaposi’s sarcoma in AIDS. Am J Dermatopathol 1987;9:388-398.
16. Beretta G, Brambilla L, Dalla Valle G, et al: Polychemotherapy of Kaposi’s sarcoma: Evaluation of cpirubicin, bleomycin, vinblastine (EBV) combination (abstract 712). ECCO 3: Conf Clin Oncol;Cancer Nursing. Stockholm 1985, p 184.